You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous Hematopoietic Stem Cell Transplant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Systemic Lupus Erythematosus, Systemic Sclerosis Trial in Philadelphia (Depletion of CD3/CD19 in an autologous stem cell

Recruiting
  • Systemic Lupus Erythematosus
  • Systemic Sclerosis
  • Depletion of CD3/CD19 in an autologous stem cell transplant
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
May 23, 2022

After Ex-vivo Gene Therapy With BIVV003 in Severe Sickle Cell

Recruiting
  • Blood and Lymphatic Diseases
  • Detroit, Michigan
    Investigational Site Number :8400001
Jul 6, 2022

Multiple Myeloma, Auto Stem Cell Transplant Trial in Hackensack (Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Auto Stem Cell Transplant
  • Hackensack, New Jersey
    John Theurer Cancer Center @ Hackensack University Medical Cente
Dec 23, 2022

Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)

Recruiting
  • Transfusion Dependent Beta Thalassemia
  • +3 more
  • EDIT-301
  • Oakland, California
  • +3 more
Jan 3, 2023

Multiple Myeloma Trial in United States (Plinabulin)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Jun 17, 2022

Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Multiple Myeloma Trial in United States (Iberdomide)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +7 more
Jun 10, 2022

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell Trial in China (Chidamide, Cladribine, Gemcitabine)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, T-Cell
  • Deyang, Deyang, China
  • +10 more
Jul 21, 2022

Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)

Active, not recruiting
  • Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Complication of Transplanted Organ, Nos Trial in Ottawa, Toronto (Autologous Hematopoietic Stem Cell Transplant)

Completed
  • Complication of Transplanted Organ, Nos
  • Autologous Hematopoietic Stem Cell Transplant
  • Ottawa, Ontario, Canada
  • +1 more
Apr 27, 2021

CIBMTR Research Database

Recruiting
  • Autologous Stem Cell Transplantation
  • +6 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 20, 2023

    Plasma Cell Myeloma Trial in Jacksonville (procedure, biological, drug)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +2 more
    • Jacksonville, Florida
      Mayo Clinic in Florida
    Mar 25, 2022

    Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)

    Completed
    • Non-Hodgkin's Lymphoma
    • Plasma Cell Myeloma
    • Hematopoietic Cell Transplantation
    • +2 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Nov 16, 2022

    AL Amyloidosis Trial (procedure, drug, other)

    Not yet recruiting
    • AL Amyloidosis
    • Autologous Hematopoietic Stem Cell Transplantation
    • +15 more
    • (no location specified)
    Aug 28, 2023

    Multiple Myeloma Trial in Atlanta, Chicago (procedure, drug, other)

    Recruiting
    • Multiple Myeloma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +2 more
    • Atlanta, Georgia
    • +1 more
    Feb 25, 2022

    Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,

    Active, not recruiting
    • Autologous Hematopoietic Stem Cell Transplant Recipient
    • +4 more
    • Duarte, California
      City of Hope
    Mar 17, 2022

    Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,

    Recruiting
    • Autoimmune Disease
    • +18 more
    • Anti-Thymocyte Globulin
    • +9 more
    • Denver, Colorado
    • +2 more
    Feb 1, 2023

    Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

    Recruiting
    • Relapsing Multiple Sclerosis
    • +2 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • Best Available Therapy (BAT)
    • Palo Alto, California
    • +20 more
    Jan 25, 2023

    Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6

    Withdrawn
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +9 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    COVID-19 After Autologous Hematopoietic Stem Cell

    Completed
    • Covid19
    • +4 more
    • Autologous stem cell transplantation
    • Uppsala, Sweden
      Uppsala Universitet
    Feb 7, 2022

    Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

    Active, not recruiting
    • Adult Grade III Lymphomatoid Granulomatosis
    • +23 more
    • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jan 4, 2023

    Leukemia Trial (biological, drug, procedure, radiation)

    Active, not recruiting
    • Leukemia
    • aldesleukin
    • +9 more
    • (no location specified)
    Feb 17, 2022

    Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

    Not yet recruiting
    • Recurrent Classic Hodgkin Lymphoma
    • Refractory Classic Hodgkin Lymphoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +13 more
    • (no location specified)
    Feb 2, 2023

    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Canada, United States (drug, procedure,

    Active, not recruiting
    Has Results
    • Stage I Multiple Myeloma
    • +2 more
    • Chicago, Illinois
    • +4 more
    Sep 3, 2022

    Transfusion Dependent Beta-thalassemia Trial in United States (ST-400 Investigational product)

    Active, not recruiting
    • Transfusion Dependent Beta-thalassemia
    • ST-400 Investigational product
    • Los Angeles, California
    • +5 more
    Jul 6, 2022